Oncolys BioPharma Inc. (TYO:4588)
Japan · Delayed Price · Currency is JPY 4,040.00
+20.00 (0.50%)
Aug 27, 2026, 10:15 AM JST
Oncolys BioPharma Market Cap
Oncolys BioPharma has a market cap or net worth of 118.35 billion as of August 26, 2026. Its market cap has increased by 621.69% in one year.
Market Cap
118.35B
Enterprise Value
115.96B
Revenue
28.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,040.00
ChartMarket Cap Chart
Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 118.35B, an increase of 401.11%. That is a compound annual growth rate of 13.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 118.35B | 198.97% |
| Dec 30, 2025 | 39.59B | 207.33% |
| Dec 30, 2024 | 12.88B | 18.41% |
| Dec 29, 2023 | 10.88B | 19.14% |
| Dec 30, 2022 | 9.13B | -0.44% |
| Dec 30, 2021 | 9.17B | -58.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 179.41B |
| PeptiDream | 143.22B |
| Nxera Pharma | 101.24B |
| SanBio Company | 79.46B |
| Heartseed | 54.60B |
| Cuorips | 45.35B |
| Healios K.K. | 37.40B |
| Japan Tissue Engineering | 35.78B |